Exploring the Relationship Between Different Obesity Metabolism Indices and Hyperuricemia in Patients with Hypertension and Coronary Heart Disease
Yuanyuan Li,Shanting Yi,Wencai Jiang,Meihui Gong
DOI: https://doi.org/10.2147/dmso.s491255
2024-10-19
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yuanyuan Li, 1, &ast Shanting Yi, 1, &ast Wencai Jiang, 2, &ast Meihui Gong 1 1 Cardiovascular Center of the Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, 519000, People's Republic of China; 2 Department of Cardiology, Suining Central Hospital, Suining, 629000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Meihui Gong, Cardiovascular Center of the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, People's Republic of China, Email Background: Previous studies have established a strong association between obesity, high metabolism, and the development of hyperuricemia. However, the relationship between obesity metabolism indices and hyperuricemia in high-risk patients with hypertension and coronary heart disease (CHD) remains unclear. The purpose of this study was to investigate this relationship in patients with both hypertension and CHD, and to identify the obesity metabolism index with the best diagnostic value. Methods: A two-center study encompassed 6344 participants with hypertension and CHD. Multiple logistic regression was utilized to examine the correlation between six obesity metabolism indices and hyperuricemia, with restricted cubic spline (RCS) analysis to identify non-linear relationships. Diagnostic value was assessed via receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results: Multivariable logistic regression revealed a significant correlation between increased obesity metabolism indices and hyperuricemia. Furthermore, RCS analysis revealed a nonlinear dose-response relationship (P for nonlinear < 0.001). Moreover, ROC and DCA results showed that METS-VF index, which combined visceral obesity and metabolic parameters, became the most reliable diagnostic tool. Conclusion: The study underscores a strong association between elevated obesity metabolism indices and hyperuricemia in patients with hypertension and CHD. The METS-VF index, amalgamating visceral obesity and metabolic parameters, emerged as the most reliable diagnostic tool. Keywords: obesity metabolism indices, hypertension, coronary heart disease, uric acid, hyperuricemia Uric acid (UA), a purine metabolite, accumulates in peripheral blood when its production is upregulated or excretion is diminished, culminating in hyperuricemia. 1,2 The prevalence of this condition has been escalating in tandem with enhancements in living standards and shifts in lifestyle habits. Current estimates indicate that approximately 15% of the adult population in China is affected by hyperuricemia. 3,4 Hyperuricemia has emerged as a pivotal risk factor implicated in a spectrum of disorders, including gout, diabetes, chronic kidney disease, and cardiovascular diseases (CVD). 5–8 It has become a chronic disease that garners more public attention and poses a significant challenge to public health. 9 Thus, early identification and management of hyperuricemia may reduce the disease burden and prevent adverse outcomes associated with it. A substantial body of research has established the pertinence of UA to metabolic syndrome. 10–13 However, the specific contributions of various obesity-related metabolic indices to hyperuricemia are less well characterized. Emerging evidence underscores the potential significance of obesity and metabolic abnormalities in UA metabolism dysregulation, leading to hyperuricemia. 14–16 These conditions are also central to the pathophysiology of metabolic syndrome. 17,18 Traditionally, indicators for assessing obesity and metabolism have tended to be homogeneous and lacking in accuracy. Conversely, a suite of more accessible compound markers predicated on obesity and metabolic profiles has been proposed, encompassing the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C), the triglyceride-glucose (TyG) index, the TyG to body mass index (TyG-BMI) ratio, TyG in conjunction with waist circumference (TyG-WC), the metabolic score for insulin resistance (METS-IR), and the metabolic score for visceral fat (METS-VF). 19–23 Individuals afflicted with hypertension and concomitant coronary heart disease (CHD) frequently exhibit obesity and a constellation of metabolic irregularities. 24–26 They are at an augmented risk for UA metabolism disturbances that may precipitate hyperuricemia, thereby exacerbating their susceptibility to CVD. While some studies have identified significant correlations between certain indicators, such as the TyG index or TG/HDL-C, and hyperuricemia, the clarity of these relationships within the high-risk -Abstract Truncated-
endocrinology & metabolism